MRI appearance of BRCA-associated prostate cancer.

Clin Imaging

Department of Diagnostic Radiology (OK, BRF, DJY, FVC), Oregon Health & Science University, Portland, OR, United States of America; Department Pathology & Laboratory Medicine (DEH), Oregon Health & Science University, Portland, OR, United States of America. Electronic address:

Published: April 2022

Despite advances in diagnosis and treatment, prostate cancer remains the second leading cause of cancer related mortality in men. Prognosis is variable and dependent on several clinical and genetic factors, including BRCA gene mutations. Recent clinical studies have reported that BRCA-associated prostate cancer is a more aggressive subtype with a higher probability of nodal involvement and distant metastases at the time of diagnosis, but radiological findings have not been described. Accurate recognition of those tumors could help guide clinical management and prompt testing and counseling for BRCA mutations. We have recently encountered four patients with BRCA-associated prostate cancer who underwent multiparametric MRI. The MRI appearances of these tumors, which were generally locally advanced and aggressive in appearance, are presented to facilitate recognition of BRCA-associated prostate cancer and guide potential genetic testing and counseling.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinimag.2022.02.007DOI Listing

Publication Analysis

Top Keywords

prostate cancer
20
brca-associated prostate
16
testing counseling
8
cancer
6
prostate
5
mri appearance
4
brca-associated
4
appearance brca-associated
4
cancer despite
4
despite advances
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!